Blunt Roy sold $293K of THC
Blunt Roy sold 1,000 shares of TENET HEALTHCARE CORP (THC) at $293.00 ($0.29M total) on 2026-11-11.
TENET HEALTHCARE CORP
Tenet Healthcare operates a healthcare services network for patients and provides services to hospitals, health systems, physician practices, employers and other clients. Headquartered in Dallas, Texas, Tenet has two reporting segments: Hospital Operations and Services, and Ambulatory Care. At December 31, 2025, Hospital Operations includes 50 acute care and specialty hospitals, 132 outpatient facilities, physician practices and services offered through Conifer Health Solutions. Conifer provides revenue cycle management, patient communications and engagement, and value-based care services. The Ambulatory Care segment operates through USPI, which holds ownership interests in 533 ambulatory surgery centers and 26 surgical hospitals in 37 states. USPI develops and acquires facilities, often through joint ventures with physicians or health system partners, and operates them under management services contracts. Tenet earns money by providing healthcare services and facility operations, as well as administrative and care-management services to clients.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No enriched coverage for $THC in the last 7 days.
Blunt Roy sold 1,000 shares of TENET HEALTHCARE CORP (THC) at $293.00 ($0.29M total) on 2026-11-11.
HCA Healthcare (HCA) rose 10.34% to $510.70 on November 4, 2026, following Democratic gains in the U.S. election. Investors anticipate potential policy changes favoring hospitals and Medicaid insurers. Universal Health Services (UHS) and Tenet Healthcare (THC) also saw significant gains. HCA's stock is now valued at $106.68 billion, but analysts warn of potential downside risks if policy changes do not materialize.
US hospital operators like HCA, Tenet, and UHS face revenue pressure from rising uninsured patients and reduced government aid. ACA subsidy expiration in 2026 led to premium spikes, causing 3M to drop coverage. HCA estimates a $1.2B income reduction in 2026, with Medicaid cuts expected to further impact profits in 2027 and 2028.
Recent THC coverage spans financial news, insider activity and market movers.
In the last 30 days, THC insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($293K). The most active reporter was Blunt Roy with 1 filing.
Minor insider sale may signal slight negative sentiment.
Tenet’s rally mirrors broader hospital sector gains but remains sensitive to subsidy policy.
Mixed impact: volume loss offset by less exposure in a key earnings segment.
Gain may hold if quarterly momentum continues.
Earnings beat and upgraded guidance suggest near-term upside as the market reprices higher margins from outpatient surgery.
AlphAI scores every news story that mentions THC with an AI model for sentiment and relevance, and aggregates insider trades from TENET HEALTHCARE CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.
Blunt Roy sold 1,000 shares of TENET HEALTHCARE CORP (THC) at $293.00 ($0.29M total) on 2026-11-11.
HCA Healthcare (HCA) rose 10.34% to $510.70 on November 4, 2026, following Democratic gains in the U.S. election. Investors anticipate potential policy changes favoring hospitals and Medicaid insurers. Universal Health Services (UHS) and Tenet Healthcare (THC) also saw significant gains. HCA's stock is now valued at $106.68 billion, but analysts warn of potential downside risks if policy changes do not materialize.
US hospital operators like HCA, Tenet, and UHS face revenue pressure from rising uninsured patients and reduced government aid. ACA subsidy expiration in 2026 led to premium spikes, causing 3M to drop coverage. HCA estimates a $1.2B income reduction in 2026, with Medicaid cuts expected to further impact profits in 2027 and 2028.
The article analyzes stock market reactions to the midterm elections, noting that the Dow and S&P 500 rose 3% and 1.6% respectively. Several stocks, including Vertiv (VRT), Centene (CNC), Lockheed (LMT), and GE Vernova (GEV), overreacted to the election results, while others like Vistra (VST) and Oscar (OSCR) had more measured responses.
Tenet Healthcare (NYSE:THC), which operates hospitals and surgery centers, reported a 40.8% stock increase since April. Its Q3 adjusted EPS beat estimates by 42%, with revenue up 6.5% YoY. Management raised full-year EBITDA guidance. The company benefits from a shift to higher-margin outpatient surgeries, with strong cash flow and reduced debt.
Barclays kept Tenet Healthcare's rating at Overweight and increased its price target to $297 from $271, suggesting an 11.4% upside from the Nov 3 close of $266.69. Recent analyst price targets for the company range from $300 to $342.
Truist Securities reaffirmed its Buy rating for Tenet Healthcare and increased its price target to $305, up from $290. This target suggests a 13.4% upside from the stock's Nov 2 close. Other recent analyst price targets for Tenet range from $300 to $342.
Keybanc kept its Overweight rating on Tenet Healthcare and raised its price target to $300 from $270, citing an 11.1% increase. This target suggests an 11.6% upside from the Nov 2 close of $268.89. Other recent analyst price targets for Tenet range from $304 to $342.
Leerink Partners kept its Outperform rating on Tenet Healthcare and raised its price target to $342 from $309, citing a 25.2% upside from the Oct 30 close of $273.25. Recent analyst price targets for the company range from $304 to $321.
RBC Capital kept its Outperform rating on Tenet Healthcare and raised its price target to $304 from $283, suggesting a 11.3% upside from the Oct 30 close of $273.25, according to the firm.